美敦力品牌怎么样 申请店铺

美敦力公司于1949年，由EarlE.Bakken及PalmerJ.Hermundslie建立。

美敦力于1957年制造出第一台便携式体外心脏起搏器，并于1960年制造出第一台可靠的可植入式心脏起搏系统。由此奠定了美敦力全球起搏技术领导者的地位。美敦力公司股票于纽约证交所之市，其代号为MDT。

美国美敦力公司（Medtronic,Inc.）总部位于美国明尼苏达州明尼阿波利斯市，是全球领先的医疗科技公司，致力于为慢性疾病患者提供终身的治疗方案。其主要产品覆盖心律失常、心衰、血管疾病、心脏瓣膜置换、体外心脏支持、微创心脏手术、恶性及非恶性疼痛、运动失调、糖尿病、胃肠疾病、泌尿系统疾病、脊椎疾病、神经系统疾病及五官科手术治疗等领域。每5秒钟，世界上就有一名病人因为美敦力的产品而减轻病痛，恢复健康，延长寿命。

美敦力公司现在全球120多个国家开展业务，拥有雇员3.8万名，2007财政年度全球销售额达123亿美元，列《财富》杂志美国500强企业排名第235位及美国100家卓越雇主第71位（《财富》中文版，2007年1月）。根据美国《商业周刊》2005年的调查，美敦力公司股票市值位列全球1000家最大公司的第54位。
我们业务的核心是：帮助临床专家发展各种治疗影响病人健康的解决方案：

心脏节律疾病管理—专注于管理各种影响病人健康的心脏节律疾病。美敦力各业务部门团结协作，遵照我们广泛的战略，提供解决病人心脏问题的创新性的终身解决方案。

神经，脊椎及五官科—提供包括神经刺激系统，药物输注系统，神经手术植入设备，手术辅助设备，针对长期疼痛，神经科，泌尿科及胃肠科的诊断及治疗系统，以及治疗眼、耳、鼻、喉疾病的手术设备。

心脏外科—提供业界最为广泛的心脏手术产品系列。我们为心脏手术医生，灌注师，麻醉师及他们的病人提供业界领先的产品。

心血管—提供完整的微创介入产品，包括冠脉支架，支架移植产品，血管成形球囊，导引导管，导丝及治疗冠状动脉疾病，周边血管，血管内及神经血管疾病的辅助产品。

糖尿病—提供体外胰岛素输注泵及一次性输注耗材，连续血糖监测系统以及可植入式胰岛素输注泵。

Medtronic was founded in 1949 by Earle. Bakken and Palmer J. hermundslie. Medtronic manufactured the first portable external cardiac pacemaker in 1957 and the first reliable implantable cardiac pacing system in 1960. Thus, the position of global pacemaker technology leader of Medtronic was established. Medtronic's stock is traded on the New York Stock Exchange under the symbol MDT. Medtronic, Inc., headquartered in Minneapolis, Minnesota, USA, is a leading medical technology company in the world, dedicated to providing lifelong treatment programs for patients with chronic diseases. Its main products cover arrhythmia, heart failure, vascular disease, heart valve replacement, extracorporeal heart support, minimally invasive heart surgery, malignant and non malignant pain, dyskinesia, diabetes, gastrointestinal disease, urinary system disease, spine disease, nervous system disease and surgical treatment of facial features. Every five seconds, there is a patient in the world who is relieved of pain, restored to health and extended life due to Medtronic products. Medtronic now operates in more than 120 countries with 38000 employees. In fiscal year 2007, its global sales reached US $12.3 billion, ranking No. 235 among Fortune 500 companies in the United States and No. 71 among 100 outstanding employers in the United States (Chinese version of fortune, January 2007). According to a 2005 survey by BusinessWeek, Medtronic's stock market value ranks 54th among the world's 1000 largest companies. The core of our business is to help clinical experts develop solutions to treat patients' health problems: Heart Rhythm Disease Management - focusing on the management of various heart rhythm diseases that affect patients' health. Medtronic's business units work together to provide innovative, life-long solutions to patients' heart problems in line with our broad strategy. Neurology, chiropractic and facial features department - provide the diagnosis and treatment system for long-term pain, neurology, urology and gastroenterology, as well as the surgical equipment for the treatment of eye, ear, nose and throat diseases, including the nerve stimulation system, drug infusion system, neurosurgical implantation equipment, surgical auxiliary equipment. Cardiac surgery - provides the industry's broadest range of cardiac surgery products. We provide industry leading products for cardiac surgeons, perfusion specialists, anesthesiologists and their patients. Cardiovascular - provide complete minimally invasive interventional products, including coronary stent, stent transplant products, angioplasty balloon, guide catheter, guide wire and auxiliary products for the treatment of coronary artery disease, peripheral vascular, intravascular and neurovascular diseases. Diabetes - provide in vitro insulin infusion pump and disposable infusion consumables, continuous blood glucose monitoring system and implantable insulin infusion pump.

本文链接： https://brand.waitui.com/23e399290.html